Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview

Clicks: 310
ID: 112977
1996
Use of ribavirin in infants with respiratory syncytial virus lower respiratory tract infection is not supported by evidence of significant benefit. However, previous studies lack sufficient power to rule out a potential reduction in mortality rate or respiratory deterioration. A large randomized con …
Reference Key
ag1996archivesribavirin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Randolph AG;Wang EE;;
Journal archives of pediatrics & adolescent medicine
Year 1996
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8790125
Keywords
respiration meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome Infant newborn length of stay Artificial respiratory function tests respiratory tract infections / mortality antiviral agents / therapeutic use* ribavirin / therapeutic use* respiratory syncytial virus infections / drug therapy* respiratory tract infections / drug therapy* respiratory syncytial virus infections / mortality respiratory syncytial virus infections / physiopathology pmid:8790125 doi:10.1001/archpedi.1996.02170340056011 a g randolph e e wang oxygen inhalation therapy research design respiratory tract infections / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.